Ms. Pribyl has a background as a research scientist in B cell immunology and facilities coordinator at the University of Minnesota Cancer Center. She has been a project manager at PharmaDirections since 2012. Her stellar organization and communication skills enable her to effectively coordinate pharmaceutical consulting teams and implement plans to encompass all aspects of drug development from discovery to Phase II. Ms. Pribyl can successfully guide her clients in a decentralized virtual environment.
Ms. Leins has 25 years of experience in the biopharmaceutical and in-vitro diagnostic industry with 15 years in project management roles. In addition to numerous therapeutic project assignments, Ms. Leins has also managed in vitro diagnostic projects for BioMERIEUX. Her technical background was with Rhone Poulenc Rorer in Process Development, Cell Culture, Aseptic Processing of biologic drugs. She also has experience managing GMP facilities. Ms. Leins has a PMP from the Project Management Institute.
Dr. Lallos has over 20 years of drug discovery and development expertise for emerging and growth stage biotech companies with a focus on infectious disease, antiviral, and oncology research from discovery through Phase I clinical trials. As Project Leader for PharmaDirections, Inc., Dr. Lallos is responsible for client development and project management for the firm’s emerging biotech clients. She is responsible for the execution of client development plans, developing strategic plans, managing vendor relationships, and assisting her clients’ obtaining SBIR/STTR, venture capital, and other forms of financing. Prior to working with PharmaDirections, Lisa was a Senior Scientist at Idenix Pharmaceuticals where she was part of the team that successfully characterized anti-HCV compounds for single and combination resistance. She also led the Biology Protease Inhibitor Team, contributed to eight anti-HCV IND applications, and designed and implemented new experimental methods that increased sensitivity and reduced both time and cost. Earlier in her career, in addition to managing the virology department at Aphios Corporation, she was responsible for procuring HIV and influenza antiviral NIH SBIR grants, as well as designing innovative approaches to extend the firm’s core viral research into new areas including influenza, smallpox, and parvovirus. Additionally, she served on the board of the Boston chapter of the Healthcare Businesswomen’s Association as Director Programming and Secretary, receiving a LEAD award in 2013. Dr. Lallos has a BA in Biology from Oberlin College, received her MS and PhD in Viral Immunology from New York University, and completed her postdoctoral training at Harvard University. Dr. Lallos has over ten peer-reviewed publications and holds two patents.
Dr. DeLozier received her Ph.D. in health sciences at the University of South Australia in 2001. Prior to coming on board to PDI, Dr. Delozier has vast experience as a researcher in various academic institutions and has provided project management support in various clinical-related projects. Dr. DeLozier has provided project management support at PDI since 2009, and is responsible for oversight, management and guidance of drug development programs. She also manages the operation of multi-disciplinary project teams and coordination of their activities including fiscal management and supervision of external vendors.
Ms. Damphousse has 20 years of experience in the biopharmaceutical industry with special training in Biotechnology Project Management. She has managed projects for Pharmadirections for over 7 years including support of both CMC and nonclinical IND enabling activities for small molecules and biologics. She provides project momentum to meet milestones through vendor, timeline, budget and meeting management. Ms. Damphousse also has 10 years of experience as an R&D scientist in both start-ups and big pharma.